Investing in Biotage

Biotage AB launches share buy-back

Resolutions at the Annual General Meeting in Biotage AB on April 25, 2013

Interim report January - March 2013

Biotage and Peptide Synthesis

Coming soon: Isolera™ Dalton - Flash Chromatography with Integrated Mass Identification

ISOLUTE® Myco SPE columns, a dedicated product for the efficient extraction of mycotoxins from food matrices

TLC-to-Step Gradient capability significantly reduces both purification time and solvent use

Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation

Biotage unveils Universal Phase Separators, solving an age old problem

Information for shareholders, analysts and potential investors	Corporate Governance Press Releases Financial Reports Latest Annual Report Calendar Contacts Subscribe
Biotage is listed on the NASDAQ OMX Nordic Stockholm Stock Exchange. The stock exchange identity is BIOT.

Print page